Cytolytic Vaginosis Multicentre Registry
Launched by UNIVERSITY OF ALBERTA · Jan 18, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Cytolytic Vaginosis Multicentre Registry is a research study aimed at understanding a condition called cytolytic vaginosis, which affects some women and is not widely known. The study seeks to answer important questions about this condition, such as what causes it, what symptoms women experience, how it can be diagnosed, and whether a treatment involving baking soda vaginal rinses is helpful. Researchers are also interested in seeing if the characteristics of cytolytic vaginosis differ between women from different locations.
If you're a woman aged 65-74 who has symptoms of vaginitis (irritation or inflammation of the vagina) and have specific findings on a microscope test called a wet mount, you may be eligible to participate. However, if you are pregnant or have a yeast infection, you won't be able to join. Participants in this study can expect to help researchers gather valuable information that could improve understanding and treatment of cytolytic vaginosis. This registry is currently looking for volunteers, so if you think you might qualify, you can reach out for more information.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Vaginitis symptoms
- • Predominately lactobacilli or/and elongated lactobacilli on wet mount
- • Cytolysis on wet mount
- Exclusion Criteria:
- • Unable to consent or decline consent
- • Pregnant
- • Positive for yeast (culture or PCR)
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto, , Portugal
Niterói, Rio De Janeiro, Brazil
Multiple Locations, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported